ENCELADUS BIO Trademark

Trademark Overview


On Wednesday, November 16, 2022, a trademark application was filed for ENCELADUS BIO with the United States Patent and Trademark Office. The USPTO has given the ENCELADUS BIO trademark a serial number of 97679595. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, June 4, 2024. This trademark is owned by FirstLight Bio, Inc.. The ENCELADUS BIO trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

pharmaceutical and biological preparations based on genome editing and engineering for use in human therapeutics, namely, for the treatment of cancer and/or genetic diseases

medical and scientific research information in the field of genome editing and engineering, gene modulation, gene repair, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; Pharmaceutical research and development; Pharmaceutical research services; Providing medical research and scientific research information in the fields of genome editing and engineering, gene modulation, gene repair, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy
enceladus bio

General Information


Serial Number97679595
Word MarkENCELADUS BIO
Filing DateWednesday, November 16, 2022
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, June 4, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 2, 2024

Trademark Statements


Goods and Servicespharmaceutical and biological preparations based on genome editing and engineering for use in human therapeutics, namely, for the treatment of cancer and/or genetic diseases
NOT AVAILABLE"BIO"
Goods and Servicesmedical and scientific research information in the field of genome editing and engineering, gene modulation, gene repair, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; Pharmaceutical research and development; Pharmaceutical research services; Providing medical research and scientific research information in the fields of genome editing and engineering, gene modulation, gene repair, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, December 7, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, December 7, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameENCELADUS BIO, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York City, NY 10019

Party NameENCELADUS BIO, INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressNEW YORK CITY, NY 10019

Party NameFirstLight Bio, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10016

Trademark Events


Event DateEvent Description
Saturday, November 19, 2022NEW APPLICATION ENTERED
Wednesday, December 7, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 16, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, June 16, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, June 16, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, June 16, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, August 29, 2023ASSIGNED TO EXAMINER
Monday, September 4, 2023NON-FINAL ACTION WRITTEN
Monday, September 4, 2023NON-FINAL ACTION E-MAILED
Monday, September 4, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 4, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Monday, December 4, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Tuesday, January 23, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, January 23, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, January 23, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, January 23, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, January 23, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, February 21, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, February 22, 2024EXAMINERS AMENDMENT -WRITTEN
Thursday, February 22, 2024EXAMINERS AMENDMENT E-MAILED
Thursday, February 22, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, February 22, 2024EXAMINER'S AMENDMENT ENTERED
Thursday, February 22, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 13, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 2, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 4, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 2, 2024PUBLISHED FOR OPPOSITION
Friday, October 11, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, October 11, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, October 11, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, October 11, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, October 11, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED